These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21834684)

  • 1. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
    Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
    Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
    Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
    J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
    Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
    Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain.
    Chen CR; McLachlan SM; Rapoport B
    J Biol Chem; 2011 Feb; 286(8):6219-24. PubMed ID: 21190937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
    Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.
    Sanders J; Miguel RN; Bolton J; Bhardwaja A; Sanders P; Nakatake N; Evans M; Furmaniak J; Smith BR
    Thyroid; 2007 Aug; 17(8):699-706. PubMed ID: 17725428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.
    Sanders J; Chirgadze DY; Sanders P; Baker S; Sullivan A; Bhardwaja A; Bolton J; Reeve M; Nakatake N; Evans M; Richards T; Powell M; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2007 May; 17(5):395-410. PubMed ID: 17542669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody protection reveals extended epitopes on the human TSH receptor.
    Latif R; Teixeira A; Michalek K; Ali MR; Schlesinger M; Baliram R; Morshed SA; Davies TF
    PLoS One; 2012; 7(9):e44669. PubMed ID: 22957097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
    Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
    Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain.
    Chen CR; Tanaka K; Chazenbalk GD; McLachlan SM; Rapoport B
    J Biol Chem; 2001 May; 276(18):14767-72. PubMed ID: 11278376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
    Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.